APA (7th ed.) Citation

Smit, E. F., Theelen, W. S. M. E., Smeenk, M. M., Noort, V. v. d., Hendrikx, J. M. A., & Kalkhoran, H. A. Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: A real-world, retrospective bicenter cohort study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Smit, Egbert F., Willemijn S M E. Theelen, Michiel M. Smeenk, Vincent van der Noort, Jeroen M A. Hendrikx, and Hanieh Abedian Kalkhoran. Pembrolizumab Hybrid Dosing Is Non-inferior to Flat Dosing in Advanced Non-small Cell Lung Cancer: A Real-world, Retrospective Bicenter Cohort Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Smit, Egbert F., et al. Pembrolizumab Hybrid Dosing Is Non-inferior to Flat Dosing in Advanced Non-small Cell Lung Cancer: A Real-world, Retrospective Bicenter Cohort Study. BMJ Publishing Group.